I am considering utilizing the Bard PowerGlide Midline at our facility. My question #1 is insertion with or without maximum barrier precautions.
I went to the INS standards for my guidance;
Under the heading of VASCULAR ACCESS SITE PREPARATION AND DEVICE PLACEMENT
S44 #35 Practice criteria for Short Peipheral and Midline Catheters; SECTION C says: The nurse should use a new pair of disposable , nonsterile gloves in conjuntion with a no-touch technique for peripheral IV insertion. With no touch technique , the planned IV inseriton site is not palpated afer skin cleansing unless sterile gloves are worn.
So, if I am reading this right it is not inserted sterile at all. I realize it said peripheral IV , but it does not state anything different for MIdline insertion and the Subtitle of the section is; Short Peripheral and Midline Catheters.
However as I read in old posts Lynn and several others of much experience are saying to use max barrier precautions. After years of using this product what is everyones opinion now??? My info I quoted above was from the most recent INS Standards.
question #2 It says S37section 32 : VASCULAR ACCESS DEVICE SELECTION; Practice Criteria for Midline catheters; B. Therapies not approrpiate for midline catheters include continuous vesicant therapy,........... So....does that mean it is okay to utilize these devices for intermittent vessicant therapy such as Vancomycin? or are we going by the ph factor it discusses below in remaining statement?? where Vanco ph is anywhere from 2.4 - 5?? and say no we cant administer it because of PH??
thank you in advance, Gina Ward R.N.
question #1 I have recently started placing powerglides, certainly there are more expert placers that will hopefully speak up here. I personally feel anything going in a vein should be sterile, most definitely a midline catheter. As I understand it, some of the reasons for max barrier is to prevent contamination of the wire as it might whip around, and the catheter itself during insertion. With powerglide, those components are neatly contained during the procedure. In my opinion, head to toe max barrier for powerglide insertion is overkill.
question #2 That word "continuous" has confused me too. However, once I saw a vanc infiltration in a midline, the answer to that question is perfectly clear. In the words of Nancy Reagan "just say no". There may be changes in the future, we will see.
Thanks for the discussion points Gina!
Hello,
We use the BARD Poly non-power-injectable single lumen, 4 FR catheter. We use the max barrier tray (REF 4154108D). Our team uses max barrer because we do not want to introduce infection, because we are all also PICC inserters and the max barrier is a habit, because we cover the probe with a sterile probe cover and do not want it to drag across a non-sterile table, and because these are pre-operative surgical patients. We do not want to take a risk of introducing an infection prior to this surgical procedure (bariatric). I interpret "unless sterile gloves are worn" as applicable to the midline insertion technique we use and take all precautions. I am also starting to reach for sterile gloves when using U/S to place a PIV on some of our more difficult access patients.
Hope this helps.
Carole
Intermittent is confusing. Also, I think the blanket term "vesicant" can be misleading because not all vesicants are administered the same way. In oncology, which frankly is where most poeple think of vesicants, the patient goes to the treatment center, gets IV access of some sort, gets a dose of chemo and the line is pulled or deaccessed. ONS used to say vesicants could go through peripheral IVs as long as they were "virgin" lines. Now they say the nurse should avoid PIVs that are over 24 hours old if possible. ONS is writing its recommendations based on drugs that are infused in a manner similar to Doxorubicin or Vincristine, where a patient gts a single dose and then is good for at least several days. Vancomycin, while still a vesicant, is infused over at least an hour. No "vesicant precautions" used like with other vesicants in oncology. Long winded way of saying that "intermittent" and "vesicant" mean different things based on the drug and how it's given. I think it comes down to thorough patient assessment and avoiding "dumbed-down" decision trees to try to decide what line is best for a patient because of a type of drug. Frankly, if midlines have the same infusion indications as PIVs, then Vancomycin may be given for a short duration until central access can be established because of the high likelihood that the patient will experience chemical phlebitis and related complications if infused repeatedly through a non-central line. I like that fact that ONS has changed the recommendation from "virgin line" to "should avoid a peripheral IV more than 24 hours old" because it emphasizes the importance of a holistic vascular access needs assessment.
Keith W. Gilchrist, MSN, RN, PHN, OCN, CRNI, VA-BC
Oncology Nurse Navigator, David Grant Medical Center
Travis AFB, CA
I have to correct you on this one. A vesicant is determined by the characteristics of the drug. It is any drug that can produce tissue damage, by any mechanism, if it escapes from the vein and enters the subq tissue. This could be blistering, binding to DNA causing cell death which then releases more of the drug to be taken up by other cells, ischemia from vasoconstriction, or other mechanisms. There can be debate about which drugs are actually considered to be vesicants, however the general consensus is that a vesicant drug causes tissue damage. It also is not dependent upon the type of VAD being used. It is not limited to peripheral catheters and can happen with all types of CVADs and midlines. The mechanism by which the drug escapes varies by the type of catheter.
Intermittent medications includes those that are given by push or piggyback with the time ranging from less than a minute to a short infusion of 2 hours from some high dose vancomycin or amphotericin. These drugs are then repeated PRN or on a schedule q4, 6, 8, 12, or 24 hours. Continuous infusion is when there is a constant flow of fluids or medications into the vein without interruption. This could last for several hours, days, weeks, etc.
I know the concept of a virgin line is talked about but I have never seen this recommended in print from any organization or in any studies. There has always been the concept that older peripheral catheters have a greater risk of infiltration or extravasation while those with less than 24 hours old have a smaller risk. But this risk is completely based on other factors such as site selection (hand, wrist, and ACF are known to have the greatest risk), catheter stablization and joint stabilization, along with infusion techniques.
The important points are that every nurse giving all IV medications MUST know all the information about the drug, conduct a thorough site assessment for patency of the vein and catheter before giving any medication. I was recently asked at the AVA conference, what about those nurses who don't know they are giving a vesicant? All nurses are held accountable to the same standard of care. They must know what they are giving and the possible risk associated with it and we are held accountable for the outcome of what we do. This is extends beyond "responsibility" for the task at hand. Accountability focuses on outcomes. Lynn
Lynn Hadaway, M.Ed., RN, BC, CRNI
Lynn Hadaway Associates, Inc.
126 Main Street, PO Box 10
Milner, GA 30257
Website http://www.hadawayassociates.com
Office Phone 770-358-7861
I have a lot to learn. I realize now I was "quoting" a hospital policy about the age of the ideal peripheral IV and not ONS. I sure didn't intend to misquote them! I appreciate your summary of the important point being that the nurse must be aware of the characteristics of the drug being infused and the line in which it will be infused. In my facility staffed with so many brand new nurses, I am tempted to want to create policy that over-simplifies things and takes the pressure off the individual nurse, but I understand that is really not a possibility! Thank you!
Keith W. Gilchrist, MSN, RN, PHN, OCN, CRNI, VA-BC
Oncology Nurse Navigator, David Grant Medical Center
Travis AFB, CA
I can understand that desire about the new nurses, but a better appraoch would be to help them grow professionally by increasing their knowledge and critical thinking skills. Go to our website www.hadawayassociates.com and you can download all of my articles on infiltration and extravasation. We also have started a new blog. Look for the post about Clinician vs Custodian. Lynn
Lynn Hadaway, M.Ed., RN, BC, CRNI
Lynn Hadaway Associates, Inc.
126 Main Street, PO Box 10
Milner, GA 30257
Website http://www.hadawayassociates.com
Office Phone 770-358-7861
We have not used the powerglide. We are using the Arrow SL 4fr midline. We use max barrier precautions for midlines nust like the PICCs. We only insert the midlines for short term use of non-vessicant medications but sometimes the plan changes. I have a pharmacist that I can co-sign to my notes so that will have extra eyes on the chart looking for medication changes. I have seen lots of problems with midlines after being infused with vanco.
Linda C. Smith, RN
Linda, thanks for your message. Can you give more details on the nature of the problems from vancomycin through a midline? Phlebitis, thrombophlebitis, necrotic ulcers? What were the clinical signs and symptoms in these patients? Was any type of surgical intervention required or did they heal with only medical management? Thanks Lynn
Lynn Hadaway, M.Ed., RN, BC, CRNI
Lynn Hadaway Associates, Inc.
126 Main Street, PO Box 10
Milner, GA 30257
Website http://www.hadawayassociates.com
Office Phone 770-358-7861